baber/WOPTO huggingface dataset:
Patent FI-953263-A0 (FI)
Inventor: SAMMARCO ANTHONY J
IPC: H04W52/02
Filed: 1995-06-30
Abstract: A communications system in which information is transmitted in successive time slots grouped into a plurality of superframes which are, in turn, grouped into a plurality of hyperframes. A remote station is assigned to one of the time slots in each of the superframes for paging the remote station, each hyperframe including at least two superframes, and the information sent in the assigned time slot in one superframe in each hyperframe is repeated in the assigned time slot in the other superframe(s) in each hyperframe. Each superframe can include a plurality of time slots used for sending paging messages to remote stations, grouped into a plurality of successive paging frames, and the time slot to which the remote station is assigned is included once in every paging frame. Also, each superframe may include time slots comprising a logical channel for broadcast control information and time slots comprising a logical paging channel. Information sent in the assigned time slot may direct the remote station to read the broadcast control information, and the information may have been encoded according to an error correcting code and include a plurality of bits having polarities that are inverses of cyclic redundancy check bits produced by the encoding. Also, the broadcast control information may comprise special messages that are included in respective time slots comprising a logical special message channel, the time slots of the special message channel may be grouped in successive SMS frames, and the SMS frames may be synchronized to start with a start of a superframe.
Patent FI-962620-A0 (FI)
Inventor: LUX MARTIN
IPC: C08F4/606
Filed: 1996-06-25
Abstract: PCT No. PCT/EP94/04125 Sec. 371 Date Jun. 26, 1996 Sec. 102(e) Date Jun. 26, 1996 PCT Filed Dec. 13, 1994 PCT Pub. No. WO95/18160 PCT Pub. Date Jul. 6, 1995Homopolymers of ethylene or copolymers of ethylene with other olefins or mixtures thereof are prepared by suspension polymerization in the presence of catalyst systems by a process in which the catalyst systems used are those which contain, as active components, A) a finely divided carrier treated with trialkylaluminum, B) a metallocene complex, C) an open-chain or cyclic alumoxane compound and D) an alkali metal alkyl or alkaline earth metal alkyl or a mixture thereof.
Patent FI-964817-A0 (FI)
Inventor: KINNUNEN KIMMO
IPC: H04W16/14
Filed: 1996-12-02
Abstract: A method of maintaining a group call in a mobile communication system comprising a network infrastructure and mobile stations, the method comprising the steps of: establishing a group call in which a first mobile station is prioritized and the mobile stations participating in said group call communicate in speech items, the frame structure comprising time slots that a second mobile station sending a speech item employs in its speech item. In the method, the first mobile station is allocated time slots or time periods in which only the first mobile station can transmit signalling messages to the network infrastructure; the first mobile station and the third mobile stations are transmitted data indicating in which time slots of time periods only the first mobile station can send signalling messages to the network infrastructure; and the third mobile stations refrain from sending their signalling messages in the time slots or time periods allocated to the first mobile station.
Patent FI-973197-A0 (FI)
Inventor: KAMEN DEAN L
IPC: B62K3/00
Filed: 1997-08-01
Abstract: There is provided, in a preferred embodiment, a transportation vehicle for transporting an individual over ground having a surface that may be irregular. This embodiment has a support for supporting the subject. A. ground-contacting module, movably attached to the support, serves to suspend the subject in the support over the surface. The orientation of the ground-contacting module defines fore-aft and lateral planes intersecting one another at a vertical. The support and the ground-contacting module are components of an assembly. A motorized drive, mounted to the assembly and coupled to the ground-contacting module, causes locomotion of the assembly and the subject therewith over the surface. Finally, the embodiment has a control loop, in which the motorized drive is included, for dynamically enhancing stability in the fore-aft plane by operation of the motorized drive in connection with the ground-contacting module. Included in the control loop is a directional control, letting the vehicle move, lean and turn in response to an indication of the subject, e.g. that of leaning the vehicle. The ground contacting module may be realized as a pair of ground-contacting members, laterally disposed with respect to one another. The ground-contacting members may be wheels, a duster of wheels, or includes rotatably mounted arcuate element pairs.
Patent IL-62308-A0 (IL)
Title: 1-(acylamino-aryloxy)-3-alkynylamino-propan-2-ols,their preparation and pharmaceutical compositions containing them
IPC: A61K31/505
Filed: 1981-03-06
Abstract: The invention relates to a compound of the formula   <IMAGE> wherein R1 is a linear or branched alkyl of 4 to 20 carbon atoms; R2 is hydrogen, halogen, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms or a bivalent radical -CH=CH-CH=CH- or -(CH2)n-, where n is an integer from 3 to 5, inclusive, and the free bonds of said bivalent radical are attached to adjacent carbon atoms of the phenyl ring; and R3 is hydrogen or alkyl of 1 to 3 carbon atoms; R4 is alkyl of 1 to 3 carbon atoms; or R3 and R4, together with each other, are -(CH2)p-, where p is an integer from 4 to 6, inclusive, or a non-toxic, pharmacologically acceptable acid addition salt thereof. The compounds of formula I are useful for treatment and prophylaxis of diseases of the coronaries, for the treatment of hypertension, and for treatment of cardiac arrhythmia, particularly tachycardia.
Patent IL-67498-A0 (IL)
Title: Pyrrole derivatives,their preparation and their use as microbicides
IPC: A01N43/34
Filed: 1982-12-16
Abstract: 1. Claims for Contracting States BE, CH, DE, FR, GB, IT, LI, NL Compounds of the general formula I  see diagramm : EP0096142,P25,F1 wherein R1 is a fragment [X, Y, Z(phenyl)], [X, Y, Z(biphenyl)], [U, V, W(pyridyl)], [U, V, W(furyl)] or [U, V, W(thienyl)], wherein X, Y and Z are each independently hydrogen, halogen, C1 -C4 alkyl, C1 -C3 haloalkyl, di(C1 -C4 alkyl)amino, nitro, cyano, -COO(C1 -C4 alkyl), -CON(C1 -C4 alkyl)2 or the group -E-R4 , wherein E is -O-, -S-, -SO- or -SO2 -, R4 is C1 -C6 alkyl which is unsubstituted or substituted by C1 -C4 alkoxy, unsubstituted C3 -C5 alkenyl, C3 -C5 alkynyl which is unsubstituted or substituted by halogen or hydroxy, or is [X, Y, Z(phenyl)] or -CH2 -[X, Y, Z-(phenyl)] ; U, V and W are each independently hydrogen, halogen or C1 -C4 alkyl ; R2 is -COO(C1 -C6 alkyl), -CO-(C1 -C6 alkyl), -CO-N(C1 -C6 alkyl)2 , cyano, nitro, -SO2 -(C1 -C6 alkyl), -P(O)-(C1 -C6 alkoxy)2 or -SO2 -N(C1 -C6 alkyl)2 ; and R3 is C1 -C3 haloalkyl. 1. Claims for Contracting State AT A microbicidal composition for controlling or preventing an attack on living plants and/or for preserving perishable storable goods of vegetable or animal origin, which composition contains, as at least one active component, one of the compounds of the general formula I see diagramm : EP0096142,P27,F1  wherein R1 is a fragment [X, Y, Z(phenyl)], [X, Y, Z(biphenyl)], [U, V, W(pyridyl)], [U, V, W(furyl)] or [U, V, W(thienyl)], wherein X, Y and Z are each independently hydrogen, halogen, C1 -C4 alkyl, C1 -C3 haloalkyl, di(C1 -C4 alkyl)amino, nitro, cyano, -COO(C1 -C4 alkyl), -CON(C1 -C4 alkyl)2 or the group -E-R4 , wherein E is -O-, -S-, -SO- or -SO2 -, R4 is unsubstituted C1 -C6 alkyl, C3 -C5 alkenyl which is unsubstituted or substituted by halogen, C3 -C5 alkynyl which is unsubstituted or substituted by halogen or hydroxy, or is [X, Y, Z(phenyl)] or -CH2 -[X, Y, Z(phenyl)] ; U, V and W are each independently hydrogen, halogen or C1 -C4 alkyl ; R2 is -COO(C1 -C6 alkyl), -CO-(C1 -C6 alkyl), -CO-N(C1 -C6 alkyl)2 , cyano, nitro, -SO2 -(C1 -C6 alkyl), -P(O)-(C1 -C6 alkoxy)2 or -SO2 -N(C1 -C6 alkyl)2 ; and R3 is C1 -C3 haloalkyl.
Patent IL-71097-A0 (IL)
Title: Liquid formulations of dihydropyridines and their preparation
IPC: A61K9/10
Filed: 1984-02-28
Abstract: A rapidly absorbable liquid formulation of a dihydropyridine comprising, by weight, about 0.5 to 10 parts of a dihydropyridine of the formula   <IMAGE>   in which R1 is C1-C4-alkyl, optionally substituted by C2-C3-alkoxy, R2 is C1-C10-alkyl, optionally substituted by C1-C3-alkoxy, trifluoromethyl or N-methyl-N-benzylamino, R3 is C1-C4-alkyl, cyano or hydroxymethyl, and X is 2- or 3-nitro, 2,3-dichloro or 2,3=N-O-N=, 20 to 60 parts of a solubilizing agent and 80 to 40 parts of a diluent.
Patent IL-80216-A0 (IL)
Title: 3-vinyl-and 3-ethinyl-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: A61K31/435
Filed: 1986-10-02
Abstract: Compounds of formula I    <IMAGE>  (I)  wherein R1 is hydrogen or a protecting group, R2 is -CH=CR24 or -C 3BOND CR4, R4 is hydrogen or halogen, R3 is hydrogen, lower alkyl or lower alkoxyalkyl, RA is, inter alia, hydrogen, OR7, lower alkyl, which optionally is substituted with aryl, lower alkoxy or NR5R6, R5 and R6 can be the same or different and in each case is hydrogen, lower alkyl or together with the nitrogen atom a 5-6 member ring, which can contain another heteroatom, R7 is lower alkyl, optionally substituted aryl or aralkyl, and each compound can contain one or more RA radicals which are not hydrogen, have valuable pharmacological properties.
Patent IL-90279-A0 (IL)
Title: Piperazinyl carboxamide derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P25/18
Filed: 1989-05-12
Abstract: The invention discloses compounds of the formula (I) <CHEM> wherein R<1> is 1-adamantyl, 3-methyl-1-adamantyl, 3-noradamantyl, unsubstituted or substituted-2-indolyl, 3-indolyl, 2-benzofuranyl and 3-benzofuranyl wherein the substituents are selected from lower alkyl, lower alkoxy and halo; R<2> is unsubstituted or substituted phenyl, benzyl, pyridinyl, pyrimidinyl or pyrazinyl, wherein the substituents are selected from lower alkyl, lower alkoxy, trifluoromethyl and halo; R<3> is H or lower alkyl of 1 to 3 carbon atoms, n is the integer 0 or 1; m is an integer from 2 to 5, and the pharmaceutically acceptable salts thereof which possess central nervous system activity.
Patent IL-92380-A0 (IL)
Title: Phenylaliphatylaminoalkanediphosphonic acids
IPC: A61K31/66
Filed: 1989-11-21
Abstract: Phenylaliphatylaminoalkanediphosphonic acids of the formula   <IMAGE> (I)  in which R1 is an aliphatic hydrocarbon radical having 4 and not more than 7 C atoms and substituted by phenyl, R2 is a monovalent aliphatic hydrocarbon radical having 1 and not more than 4 C atoms and alk is a divalent aliphatic hydrocarbon radical having 2 and not more than 4 C atoms, and their salts, have a particularly pronounced regulating action on calcium metabolism and can be used as medicaments for the treatment of diseases to be attributed to disturbances thereof. They are prepared, for example, for reacting a compound of the formula   <IMAGE> (V)  in which X3 denotes carboxyl, with a phosphorylating agent and hydrolyzing the primary product.
Patent IL-94214-A0 (IL)
Title: Pyrotechnic priming device having a microlens set by a shape memory material and pyrotechnic chain utilizing said device
IPC: G02B6/42
Filed: 1990-04-26
Abstract: The priming device is a miniature device consisting of a hollow body (18) intended to receive a pyrotechnic substance (24), a rigid graded index microlens (30) mounted in the hollow body to focus a high energy beam of given wavelength on to the pyrotechnic substance, a short length of tubing (32) made of a shape-memory metal or alloy housed in the body (18) and ensuring that the microlens is locked in the body of the device. At room temperature, the inner diameter of the length of tubing is less than the diameter of the lens. The microlens- tubing assembly and the optical fibre (12) carrying the laser beam are held in position by a connector (34) fixed on to the body (18). 
<IMAGE>
Patent IL-95578-A0 (IL)
Title: Vaccine formed from a poly-saccharide and a protein
Inventor: MICHEL JAMES L
IPC: C12P21/00
Filed: 1990-09-04
Abstract: A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine is formed by conjugating (a) a polysaccharide conjugated to (b) a protein; wherein both the polysaccharide and the protein are characteristic molecules of the group B Streptococcus.
Patent IL-98241-A0 (IL)
Title: Ingestibles containing substantially tasteless sweetness inhibitors and methods for reducing the bitter taste in substances
IPC: A23L27/40
Filed: 1991-05-23
Abstract: Sweetness inhibitors which are substantially tasteless have been found to be bitter taste inhibitors or blockers. Conversely, bitter taste inhibitors which are substantially tasteless have been found to be sweet taste inhibitors or blockers.
Patent FI-20065697-A0 (FI)
Inventor: HANNUNIEMI HENRI
IPC: G16H40/20
Filed: 2006-11-06
Abstract: The present invention relates to a medical information management arrangement that uses wireless data transmission. The invention also relates to a wireless terminal (105) used in the data transmission network, a wireless sensor belt (109), and a departmental server (100) managing the medical information network, and a medical radio beacon (60).
Patent IL-107040-A0 (IL)
Title: Modified platelet factor-4
IPC: C12P21/02
Filed: 1993-09-20
Abstract: The present invention is based of the discovery of two modified forms of human platelet factor-4, herein named MPF-4 and CPF-4, which were isolated from serum free culture medium of lipopolysaccharide-stimulated peripheral blood leukocytes. Amino acid sequence determination revealed that MPF-4 shares homology with platelet factor-4 beginning at N-terminal residue 17. CPF-4 consists of MPF-4 disulfide bonded to the 16 N-terminal residues of platelet factor-4. Both MPF-4 and CPF-4 are potent inhibitors of endothelial cell proliferation, approximately 10-100 fold more potent than native or recombinant platelet factor-4, making them useful in the treatment of angiogenic diseases.
Patent IL-108444-A0 (IL)
Title: C2 taxane derivatives and pharmaceutical compositions containing them
IPC: C07D493/08
Filed: 1994-01-26
Abstract: Taxane derivatives having alternative C2 substituent which is -OCOR31 wherein R31 is substituted phenyl and the substituent is selected from the group consisting of alkanoxy, protected hydroxy, halogen, alkyl, aryl, alkenyl, acyl, acyloxy, nitro, amino and amido.
Patent IL-109157-A0 (IL)
Title: Two component fibrin glue
IPC: A61L26/00
Filed: 1994-03-29
Abstract: PCT No. PCT/EP94/00966 Sec. 371 Date Nov. 30, 1995 Sec. 102(e) Date Nov. 30, 1995 PCT Filed Mar. 27, 1994 PCT Pub. No. WO94/22503 PCT Pub. Date Oct. 13, 1994A two-component fibrin glue for human application includes a) a component A containing i) a virus-inactivated and concentrated cryoprecipitate that contains fibrinogen, and ii) tranexamic acid or a pharmaceutically acceptable salt, thereof; and b) component B containing a proteolytic enzyme that, upon combination with component A, cleaves, specifically, fibrinogen present in the cryoprecipitate of component A, thereby, effecting a fibrin polymer.
Patent IL-109870-A0 (IL)
Title: Process for preparing crystalline beta-lactam monohydrate
IPC: C07D205/085
Filed: 1994-06-02
Abstract: Prodn. of the crystalline monohydrate form of loracarbef (I) comprises: (a) mixing a form of (I), other than the crystalline monohydrate form, in water at 30-60[deg]C; or (b) exposing a form of (I), other than the crystalline monohydrate form, to satd. steam at 90-100[deg]C.
Patent IL-110255-A0 (IL)
Title: Process and intermediate for synthesizing hiv protease inhibitors
IPC: A61K31/495
Filed: 1994-07-08
Abstract: <CHEM>   Intermediates of structural formula (A) can be made by reacting a primary or secondary amine with glycidol or an activated derivative thereof. The process and intermediates are useful for synthesizing HIV protease inhibitor compounds, particularly L-735,524. <CHEM>
Patent IL-112292-A0 (IL)
Title: Pharmaceutical compositions containing 1-aminoindan and derivatives thereof
IPC: A61K31/495
Filed: 1995-01-10
Abstract: Novel derivatives of 1-aminoindan and their salts are described. Parkinson's disease, dementia, epilepsy, convulsions, seizures, acute neurological traumatic disorder or neurotrauma are treated by administering a compound of formula (I).
Patent IL-115621-A0 (IL)
Title: Ramming system
IPC: F41A9/37
Filed: 1995-10-13
Abstract: PCT No. PCT/SE95/01180 Sec. 371 Date Jun. 2, 1997 Sec. 102(e) Date Jun. 2, 1997 PCT Filed Oct. 13, 1995 PCT Pub. No. WO96/12153 PCT Pub. Date Apr. 25, 1996A method and an apparatus for loading artillery guns intended for non-cartridge ammunition is provided. The loading is done by a pair of flick rammers including a first flick rammer for shells and a second flick rammer for propellant charges. Each of the flick rammers is positioned at an end position where the flick rammers are loaded with the shell and propellant charge, respectively, and in which the gun can recoil between the flick rammers. After the first flick rammer is loaded, it is moved towards the second flick rammer into a position in which the shell in the first flick rammer is in line with a gun barrel. The first flick rammer is then activated to move the shell into the gun barrel. The flick rammers are then jointly displaced in an opposite direction until the first flick rammer is in its end position and the propellant charges in the second flick rammer are in line with the gun barrel. The second flick rammer is then activated moving the propellant charges into the gun barrel and after this the second flick rammer is returned to its end position.
Patent IL-121374-A0 (IL)
Title: A projectile having features of high deformability on impact
IPC: F42B12/72
Filed: 1997-07-23
Abstract: A projectile for firearms has a body (11) consisting of a plurality of disc-shaped elements (14) coaxially fitted in a holding cup (15) forcedly filled therewith. <IMAGE>
Patent IL-128092-A0 (IL)
Title: Ventilator apparatus
IPC: A61H31/02
Filed: 1997-07-16
Abstract: A cuirass type ventilator compresses a shell member having a peripheral edge and a sealing device secured to the peripheral edge, the sealing device compressing a scaling member depending from the peripheral edge of the shell, the sealing member having a sealing region for sealing against a patient's body, a securing region whereat the sealing member is secured to the shell and a resilient pleated region intermediate the sealing region and securing region whereby, in use, the resilience of the pleated region urges the sealing region into scaling engagement with a patient's body.
Patent IL-128768-A0 (IL)
Title: Transdermal therapeutic system containing oestriol
IPC: A61K9/70
Filed: 1997-08-13
Abstract: Disclosed is a transdermal therapeutical approach involving oestriol as an active substance, characterized in that oestriol is combined with one or more active substances.
Patent IL-129247-A0 (IL)
Title: Contamination-safe multiple-dose dispensing cartridge for flowable materials
IPC: B65D47/20
Filed: 1997-10-03
Abstract: A volumetrically reducible container having a dispensing cartridge (10) which is designed to dispense multiple doses of a flowable material from the collapsible container (14) and which does not produce an internal vacuum as the flowable material is dispensed. The cartridge (10) has a housing (12) for protecting a delivery block (30) enveloped by an elastic sheath (44). The delivery block (30) receives the flowable material from the collapsible container (14) through an input port (32) and delivers it through an internal channel (34) with branches to at least one output port (36, 38). Sleeve valves (46, 48) are created at the output port or ports (36, 38) by the sheath (44). The cartridge (10) prevents external contaminants from entering the container and can be mounted on tubes, bags, infusion containers, syringes, pouches, collapsible reservoirs, bellows-type containers and the like. In a particularly advantageous embodiment the dispensing cartridge (10) is permanently bonded to the container (14) to produce an integrated dispensing system. <IMAGE>
Patent IL-131655-A0 (IL)
Title: Isolation of tissue specific ligands and their use for targeting pharmaceuticals to organs
IPC: C07K7/08
Filed: 1998-03-04
Abstract: The subject invention provides novel peptides and the use of these peptides in the treatment of various diseases and conditions. The novel peptides specifically bind to undetermined and determined targets in various organs and in lymphocytes. The subject invention also provides a method for the identification of a peptide by applying peptide library methodology ex vivo to perfused organs.
Patent IL-131816-A0 (IL)
Title: Composite structures having high containment strength
IPC: F16L9/147
Filed: 1998-04-02
Abstract: Composite fiber reinforced structures, such as pipes or storage tanks, having improved resistance to microcracking and delamination and improved containment strength are disclosed. The walls of the structures comprise at least one layer comprising a plurality of continuous reinforcing glass fibers having an average diameter of <=about 10 microns impregnated in a resinous binder such as a thermoset epoxy resin.
Patent IL-134376-A0 (IL)
Title: Cylinder lock
IPC: E05B27/10
Filed: 1999-05-06
Abstract: A key for a cylinder lock has a substantially flattened and elongated body on which a ring (30) is arranged with its axis transverse to the longitudinal direction of the key and parallel to the general plane of the flattened body of the key. The ring is able to move with its axis relative to the body of the key <IMAGE>
Patent IL-161239-A0 (IL)
Title: Method for controlling electronic parcel compartment systems and an interface for carrying out said method
IPC: G07F17/12
Filed: 2002-10-07
Abstract: Disclosed herein are a method for controlling electronic parcel compartment systems and an interface for carrying out the method. According to the disclosed method, data for controlling the electronic parcel compartment systems are stored on a server and are converted into control commands for controlling the compartment systems. Furthermore, according to the disclosed method, the control commands are transmitted to the parcel compartment systems via an interface.
Patent IL-173476-A0 (IL)
Title: 8-chloro-2,3-benzodiazepine derivatives
IPC: C07D243/02
Filed: 2006-01-31
Abstract: The invention relates to new 8-chloro-2,3-benzodiazepine derivatives of the general formula (I), wherein R stands for a lower alkyl group or a group of the general formula —NH—R′, wherein R′ stands for a lower alkyl or a lower cycloalkyl group), and pharmaceutically acceptable acid addition salts thereof. The invention also encompasses a process for the preparation of said compounds, pharmaceutical compositions containing them and new intermediates useful for the preparation of the new 8-chloro-2,3-benzodiazepine derivatives. The compounds according to the invention possess AMPA/kainate receptor inhibiting activity.
Patent IL-176664-A0 (IL)
Title: Metal complexes having vitamin b12 as a ligand
IPC: A61K49/00
Filed: 2006-07-02
Abstract: The present invention relates to a metal complex of the general formula M(L)n, wherein each L is independently selected and represents a ligand and at least one L is vitamin B12 (cyanocobalamin) or a derivative thereof bound through the nitrogen atom of its cyanide group to M, which is an element selected from the transition metals, thus, forming a M-NC-[Co] moiety with [Co] representing vitamin B12 without cyanide and wherein n is 1, 2, 3, 4, 5 or 6. The complex can be prepared by mixing a precursor molecule with vitamin B12. The metal complexes can be used for radiodiagnostics, chemotherapy and radionuclide therapy.